GlassScriptPhysician profile
Justin K Smith
NPI 1275041642
$2,110.81
in general payments reported to CMS, 2019-2025
13 companies · $857 in 2025
The $857 reported for 2025 was more than what 85% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.00 · 2022: $284 · 2023: $240 · 2024: $664 · 2025: $857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,761.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,125.35 | 2023-2025 | Barrigel, Urolift |
| Myriad Genetic Laboratories, INC. | $378.06 | 2022-2024 | Myrisk |
| Janssen Biotech, INC. | $197.30 | 2025 | Erleada, Rybrevant, Carvykti |
| Urogen Pharma, INC. | $106.28 | 2023 | Jelmyto |
| Astellas Pharma US INC | $65.00 | 2021 | |
| Gilead Sciences, INC. | $50.00 | 2024 | Epclusa |
| Neurocrine Biosciences, INC. | $50.00 | 2024 | Ingrezza |
| Cycle Pharmaceuticals INC | $30.08 | 2025 | Venxxiva |
| Progenics Pharmaceuticals, INC. | $25.54 | 2023 | Pylarify |
| Immunitybio, INC. | $25.06 | 2025 | |
| Endo Pharmaceuticals INC. | $24.56 | 2022 | |
| Endo USA, INC. | $17.05 | 2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $16.53 | 2024 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.